58 related articles for article (PubMed ID: 1414376)
1. [The lead generation of protein tyrosine kinase inhibitors by quantitative structure-activity relationship analysis].
Guo ZR; Goto S; Yang GZ; Terada H
Yao Xue Xue Bao; 1992; 27(2):90-5. PubMed ID: 1414376
[TBL] [Abstract][Full Text] [Related]
2. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
Olgen S; Akaho E; Nebioglu D
Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
[TBL] [Abstract][Full Text] [Related]
4. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
Kamath S; Buolamwini JK
J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
Aflalo E; Iftach S; Segal S; Gazit A; Priel E
Cancer Res; 1994 Oct; 54(19):5138-42. PubMed ID: 7923131
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and herbicidal evaluation of novel 3-[(alpha-hydroxy-substituted)benzylidene]pyrrolidine-2,4-diones.
Zhu Y; Zou X; Hu F; Yao C; Liu B; Yang H
J Agric Food Chem; 2005 Nov; 53(24):9566-70. PubMed ID: 16302778
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
Thompson AM; Murray DK; Elliott WL; Fry DW; Nelson JA; Showalter HD; Roberts BJ; Vincent PW; Denny WA
J Med Chem; 1997 Nov; 40(24):3915-25. PubMed ID: 9397172
[TBL] [Abstract][Full Text] [Related]
8. Molecular modelling and biological evaluation of a series of hydroxylated benzylideneanilines and benzylamines designed as tyrosine kinase inhibitors.
Solomons KR; Lieberman HF; Groundwater PW; Hibbs DE; Hursthouse MB
Anticancer Drug Des; 1997 Dec; 12(8):635-47. PubMed ID: 9448703
[TBL] [Abstract][Full Text] [Related]
9. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
Ramdas L; McMurray JS; Budde RJ
Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
[TBL] [Abstract][Full Text] [Related]
10. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro.
Gazit A; Osherov N; Gilon C; Levitzki A
J Med Chem; 1996 Dec; 39(25):4905-11. PubMed ID: 8960549
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
13. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.
Gazit A; Osherov N; Posner I; Yaish P; Poradosu E; Gilon C; Levitzki A
J Med Chem; 1991 Jun; 34(6):1896-907. PubMed ID: 1676428
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties.
Brunton VG; Lear MJ; McKeown P; Robins DJ; Workman P
Anticancer Drug Des; 1996 Sep; 11(6):463-83. PubMed ID: 8836111
[TBL] [Abstract][Full Text] [Related]
16. 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.
Boschelli DH; Wang YD; Johnson S; Wu B; Ye F; Barrios Sosa AC; Golas JM; Boschelli F
J Med Chem; 2004 Mar; 47(7):1599-601. PubMed ID: 15027848
[TBL] [Abstract][Full Text] [Related]
17. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction.
Levitzki A
FASEB J; 1992 Nov; 6(14):3275-82. PubMed ID: 1426765
[TBL] [Abstract][Full Text] [Related]
18. Hansch analysis of substituted benzoic acid benzylidene/furan-2-yl-methylene hydrazides as antimicrobial agents.
Kumar P; Narasimhan B; Sharma D; Judge V; Narang R
Eur J Med Chem; 2009 May; 44(5):1853-63. PubMed ID: 19081655
[TBL] [Abstract][Full Text] [Related]
19. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
Cormanich RA; Goodarzi M; Freitas MP
Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
[TBL] [Abstract][Full Text] [Related]
20. [Molecular design and biological activity of BCR-ABL tyrosine kinase inhibitors].
Peng H; Qi J; Huang N; Xie P; Wang JX; Yang CZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):145-9. PubMed ID: 15171550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]